Novo Nordisk (NOVOB DC) Wegovy injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
Importance
Level 1
#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#US SESSION#EUROPEAN EQUITIES
© 2026 Newsquawk. All rights reserved.